Medellada, John Mike .
HRN: 24-58-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/19/2024
02/26/2024
ORAL
5ml
Q8
Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes